Jianfeng Li
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Endothelial-Targeted Metallothionein-2 shRNA Nanoparticles Alleviate Migraine-Like Symptoms.
Journal: CNS neuroscience & therapeutics
Published: March 26, 2025
Targeted delivery of BMPR2 mRNA attenuates pulmonary arterial hypertension by reversing pulmonary vascular remodeling.
Journal: Acta pharmaceutica Sinica. B
Published: February 16, 2025
Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension.
Journal: Journal of medicinal chemistry
Published: April 26, 2019
New Insights into the Ligand Nature of Carbene: Synthesis and Characterizations of Six-Coordinate Iron(II) Carbene Porphyrin Complexes.
Journal: Inorganic chemistry
Published: December 20, 2018
Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs.
Journal: Bioorganic & medicinal chemistry letters
Published: November 17, 2017
Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effect.
Journal: European journal of medicinal chemistry
Published: October 18, 2017
Synthesis, structure-activity relationships, and biological evaluation of a series of benzamides as potential multireceptor antipsychotics.
Journal: Bioorganic & medicinal chemistry letters
Published: March 04, 2016
Design, synthesis, and pharmacological evaluation of monocyclic pyrimidinones as novel inhibitors of PDE5.
Journal: Journal of medicinal chemistry
Published: November 10, 2012
WITHDRAWN: Design, synthesis and biological evaluation of 3-substituted-4-anilinequinoline as EGFR tyrosine kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: September 12, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026